- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 223/16 - BenzazepinesHydrogenated benzazepines
Patent holdings for IPC class C07D 223/16
Total number of patents in this class: 413
10-year publication summary
|
29
|
24
|
19
|
31
|
17
|
19
|
18
|
16
|
13
|
16
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Arena Pharmaceuticals, Inc. | 359 |
27 |
| Les Laboratoires Servier | 523 |
24 |
| Bolt Biotherapeutics, Inc. | 120 |
13 |
| Hoffmann-La Roche Inc. | 3546 |
11 |
| Array BioPharma Inc. | 475 |
9 |
| Otsuka Pharmaceutical Co., Ltd. | 1498 |
9 |
| Shanghai Zhimeng Biopharma Inc. | 34 |
9 |
| F. Hoffmann-La Roche AG | 7937 |
7 |
| Takeda Pharmaceutical Company Limited | 2721 |
7 |
| Cadila Healthcare Limited | 313 |
7 |
| Chengdu Anticancer Bioscience Ltd | 22 |
7 |
| Boehringer Ingelheim International GmbH | 4636 |
6 |
| Board of Regents, The University of Texas System | 5946 |
6 |
| VentiRx Pharmaceuticals, Inc. | 16 |
6 |
| Lek Pharmaceuticals d.d. | 198 |
5 |
| Urquima, S.A. | 10 |
5 |
| The Regents of the University of California | 20303 |
4 |
| Janssen Pharmaceutica N.V. | 3358 |
4 |
| Astellas Pharma Inc. | 1057 |
4 |
| Denali Therapeutics Inc. | 257 |
4 |
| Other owners | 239 |